re: 18 i would have thought... hits 17 where Well Gareth , that was right on the money as they nudge $18Guess $19 is your annswer to the obvious next question
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%